Concepedia

CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study

Philippe A. Cassier, Antoîne Italiano, Carlos Gomez-Roca, Christophe Le Tourneau, Maud Toulmonde, Michael A. Cannarile, Carola H. Ries, Anne Brillouet, Claudia Müller, Anna-Maria Jegg,

The Lancet Oncology · 2015 · 363 citations · 21 references

DOI

Concepts

References

21

Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.

Nicholas Bellamy, W. Watson Buchanan, Charles H. Goldsmith et al. · PubMed · 1988 · 7.8K citations

, , +17

Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors

George D. Demetri, Margaret von Mehren, Charles D. Blanke et al. · New England Journal of Medicine · 2002 · 4.4K citations · Full text

, , +14

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations

Helen Young, R. Baum, U. Cremerius et al. · European Journal of Cancer · 1999 · 1.7K citations · Full text

, , +16

Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy

Carola H. Ries, Michael A. Cannarile, Sabine Hoves et al. · Cancer Cell · 2014 · 1.4K citations

, , +16

Crizotinib in<i>ALK</i>-Rearranged Inflammatory Myofibroblastic Tumor

James E. Butrynski, David R. D’Adamo, Jason L. Hornick et al. · New England Journal of Medicine · 2010 · 867 citations

, , +17